89
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The potential biochemical markers of Kashin–Beck disease: a meta-analysis

, , &
Pages 633-638 | Received 21 Aug 2015, Accepted 11 Feb 2016, Published online: 21 Apr 2016
 

Abstract

Objective: The objective of this study is to explore the cytokines in serum, synovial fluid as potential biomarkers of Kashin–Beck disease (KBD) and to further understand the role of these cytokines in the pathogenesis of KBD.

Methods: A systematic electronic database search was performed from inception up to 15 March 2015. Meta-analysis was performed for cytokines more than one repetition in studies with available data. The effect size was summarized as standardized mean difference (SMD) with 95% confidence intervals (CIs) by a random effect model.

Results: A total of 18 articles were included. The pooled standardized mean differences showed the serum levels of tumor necrosis factor alpha (2.72, 95% CI: 1.8 5–3.59), interleukin-1 beta (1.21, 95% CI: 0.6 1–1.80), and nitric oxide (2.60, 95% CI: 1.5 2–3.68) were significantly higher in adult KBD patients compared with that in healthy controls.

Conclusions: There was explicit evidence showing that the tumor necrosis factor alpha, interleukin-1 beta and nitric oxide were closely related to the presence of KBD, and these cytokines played a vital role in the pathogenesis of KBD.

Disclosure statement

The authors report no declarations of interest.

Funding information

This work was supported by the National Natural Scientific Foundation of China (No. 81472924).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.